rapivab
Generic: peramivir injection
rapivab: developed by 1 company · 1 FDA decision.
rapivab evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect rapivab to BCRX; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could rapivab → BCRX affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Acute Uncomplicated Influenza
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| BIOCRYST PHARMACEUTICALS INC (BCRX) Acute Uncomplicated Influenza | Approved |
FDA Decisions1 records
Frequently asked questions
Who is developing rapivab?
rapivab is being developed by BIOCRYST PHARMACEUTICALS INC.
What is rapivab's latest FDA decision?
The most recent tracked FDA decision for rapivab is Approval, dated December 19, 2014.